Abstract:Improving peroral delivery efficiency is always a persistent goal for both small-molecule and macromolecular drug development. However, intestinal mucus barrier which greatly impedes drug-loaded nanoparticles penetration is commonly overlooked. Therefore, in this study, taking fluorescent labeled PLGA (poly (lactic-co-glycolic acid)) nanoparticles as a tool, the influence of anionic and nonionic surfactants on mucus penetration ability of nanoparticles and their mucus barrier regulating ability were studied. The movement of PLGA nanoparticles in mucus was tracked by multiple particles tracking method (MPT). Alteration of mucus properties by addition of surfactants was evaluated by rheology and morphology study. Rat intestinal villus penetration study was used to further evaluate penetration enhancement of nanoparticles. The effective diffusivities of the nanoparticles in surfactants pretreated mucus were increased by 2–3 times and the mucus barrier regulating capacity was also surfactant type dependent. Sodium dodecyl sulfate (SDS) increased the complex viscosity and viscoelastic properties of mucus, but poloxamer presented a decreased trend. Tween 80 maintained the rheological property of the mucus. With the mucus barrier regulated by surfactants, the penetration of nanoparticles in intestinal villus was obviously increased. In summary, the mucus penetration ability of nanoparticles could be enhanced by altering mucus microenvironment with surfactants. Tween 80 which largely retains the original mucus rheology and morphology properties may be a promising candidate for facilitating nanoparticle penetration through the mucus barrier with good safety profile.

Recent Advances in Mucus-Penetrating Nanomedicines for Oral Treatment of Colonic Diseases

Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems

Engineering Nanomaterials to Overcome the Mucosal Barrier by Modulating Surface Properties

Micro- and Nano-Carrier Systems: the Non-Invasive and Painless Local Administration Strategies for Disease Therapy in Mucosal Tissues

Functional Nanocarrier for Drug and Gene Delivery Via Local Administration in Mucosal Tissues

Advances of nanoparticles in transmucosal drug delivery

Nanoparticle-based Oral Delivery Systems for Colon Targeting: Principles and Design Strategies

Modulating Intestinal Mucus Barrier for Nanoparticles Penetration by Surfactants

Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery

Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa

Oral Nano-Delivery Systems for Colon Targeting Therapy.

Recent advances in oral drug delivery materials for targeted diagnosis or treatment of gastrointestinal diseases

Oral Nanotherapeutics with Enhanced Mucus Penetration and ROS-responsive Drug Release Capacities for Delivery of Curcumin to Colitis Tissues.

Mucus-penetrating Polymeric Nanoparticles for Oral Delivery of Curcumin to Inflamed Colon Tissue

Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review

Betaine-Based and Polyguanidine-Inserted Zwitterionic Micelle as a Promising Platform to Conquer the Intestinal Mucosal Barrier

Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway

Polymeric nanoparticle drug delivery technologies for oral delivery applications

Strategies and opportunities of micro/nano delivery systems for targeted therapy of ulcerative colitis: Focus on underlying mechanisms and future perspectives

Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome

Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle-cell interplay in mucosa based on physiochemical properties